Moderate dyslipoproteinemia induced inflammation and remodeling HDL and VLDL particles in post-renal transplant patients

1. Abedini S. et al., Inflammation in renal transplantation. Clin. J. Am. Soc. Nephrol., 4, 1246, 2009.10.2215/CJN.00930209270952119541816Search in Google Scholar

2. Barn K. et al.: Low levels of high-density lipoprotein cholesterol: an independent risk factor for late adverse cardiovascular events in renal transplant recipients. Transpl. Intern., 23, 574, 2010.10.1111/j.1432-2277.2009.01021.x20003032Search in Google Scholar

3. Corsetti J.P. et al.: Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein. PLoS ONE, 7 e39110, 2012.10.1371/journal.pone.0039110337762022723940Search in Google Scholar

4. de la Lora Moya M. et al.: Inflammation modulates human HDL composition and function in vivo. Atherosclerosis, 222, 390, 2012.10.1016/j.atherosclerosis.2012.02.032336164122456230Search in Google Scholar

5. Friedewald W.T., Levy R.I., Fredrickson D.S.: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin. Chem., 18 499, 1972.10.1093/clinchem/18.6.499Search in Google Scholar

6. Gao X., Jayaraman S., Gursky O.: Mild oxidation promotes and advanced oxidation prevents protein dissociation and remodeling of human plasma high-density lipoprotein in vitro. J. Mol. Biol., 376, 997, 2008.Search in Google Scholar

7. Guha M., Gursky O.: Effects of Oxidation on Structural Stability and Remodeling of Human Very Low Density Lipoprotein. Biochemistry, 49, 9584, 2010.Search in Google Scholar

8. Gungor O. et al. Serum paraoxonase 1 activity predicts arterial stiffness in renal transplant recipients. J. Atheroscler. Thromb., 18, 901, 2011.10.5551/jat.917521737961Search in Google Scholar

9. Hine D., Mackness B., Mackness M.: Coincubation of PON1, apoAI, and LCAT increases the time HDL is able to prevent LDL oxidation. IUBMB Life, 64, 157, 2012.Search in Google Scholar

10. Jonas A., Sweeny S.A., Herbert P.N.: Discoid complexes of A and C apolipoprotein with lipids and their reactions with lecithin:cholesterol acyltransferase. J. Biol. Chem., 259, 6369, 1984.Search in Google Scholar

11. Kar S. et al.: Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function. Biochim. Biophys. Acta, 1821, 1200, 2012.10.1016/j.bbalip.2012.05.00222634518Search in Google Scholar

12. Kimak E. et al.: Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoprotein, and LCAT and CETP activity in post-renal transplant patients. Cell Biochem. Biophys., 67, 695, 2013.Search in Google Scholar

13. Kimak E., Solski J., Baranowicz-Gąszczyk I., Książek A.: Serum lipids, lipoproteins, oxidative stress parameters and paraoxonase 1 (PON-1) activity in post-renal transplant patients (Tx) with stable renal function and Tx patients without and with statins therapy. Annales UMCS, SECTIO DDD, 24, 41, 2011.Search in Google Scholar

14. Kimak E. et al.: Association between moderately oxidized lowdensity lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients. JZUS-B, 12, 365, 2011.10.1631/jzus.B1000348308709221528490Search in Google Scholar

15. Lee D.M. et al.: Oxidative Stress and Inflammation in Renal Patients and Healthy Subjects. PLoS ONE, 6, e 22360, 2011.10.1371/journal.pone.0022360314563821829457Search in Google Scholar

16. Lusis A.J.: Atherosclerosis. Nature, 407, 233, 2000.10.1038/35025203282622211001066Search in Google Scholar

17. Nafar M. et al.: Oxidative stress in kidney transplantation, causes, consequences, and potential treatment. Iranian J. Kidn. Dis., 5, 357, 2011. Search in Google Scholar

18. Ribas V. et al.: Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ. Res., 95, 789, 2004.10.1161/01.RES.0000146031.94850.5f15388641Search in Google Scholar

19. Scharama Y.C. et al.: Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients. Transplant., 69, 376, 2000.10.1097/00007890-200002150-0001210706046Search in Google Scholar

20. Tian L., Fu M.: The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations. J. Endocrinol. Investig., 34, 461, 2011.Search in Google Scholar